Previous 10 | Next 10 |
2024-04-03 15:15:02 ET Wells Fargo analyst issues BUY recommendation for LUNG on April 3, 2024 02:00PM ET. The previous analyst recommendation was Buy. LUNG was trading at $8.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current anal...
2024-04-03 03:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-02 16:10:43 ET More on Pulmonx Pulmonx: Revisiting Thesis Following Management Change Pulmonx dips on Wells Fargo downgrade eyeing uncertainty over management changes Seeking Alpha’s Quant Rating on Pulmonx Read the full article on Seeking Al...
REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the appointment of Mehul Joshi as Chief Financial Officer, effective April 3, ...
2024-03-26 05:38:27 ET Summary Pulmonx Corporation's shares have performed poorly over the past year, returning -16%. The company's CEO recently announced his retirement, raising questions about potential changes in corporate strategy. In my opinion, the market for endobronchi...
REDWOOD CITY, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today announced the inducement grant of equity awards to Steve Williamson, its n...
2024-03-03 10:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
AeriSeal System Shows Promise in Limiting Collateral Ventilation, Potentially Enabling a Greater Number of Severe COPD/Emphysema Patients to Benefit from Treatment with Zephyr ® Valves, a Minimally Invasive Treatment Option Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx...
2024-02-23 11:17:07 ET More on Pulmonx Pulmonx Corporation 2023 Q4 - Results - Earnings Call Presentation Pulmonx Corporation (LUNG) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Pulmonx Historical earnings data for Pulmonx F...
2024-02-21 16:43:21 ET More on Pulmonx Seeking Alpha’s Quant Rating on Pulmonx Historical earnings data for Pulmonx Financial information for Pulmonx Read the full article on Seeking Alpha For further details see: Pulmonx GAAP EPS of -$0.36...
News, Short Squeeze, Breakout and More Instantly...
ProLung Inc Company Name:
LUNG Stock Symbol:
NASDAQ Market:
REDWOOD CITY, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader i...
U.S. stocks were higher, with the Dow Jones index gaining over 50 points on Thursday. Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) rose sh...
A look at the top 10 most actives in the United States Allarity Therapeutics Inc. (ALLR) rose 97.8% to $2.71 on volume of 44,141,232 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 1.1% to $0.0456 on volume of 28,670,184 shares Emergent Biosolutions Inc. (EBS) rose 67.7% to $3...